ArticleJournal of the anus, rectum and colon2025
Preoperative MRI Assessment of Mesorectal Lymph Node Metastasis in Patients with Rectal Cancer: A Retrospective Study.
Article in Journal of the anus, rectum and colon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to determine the optimal cutoff values for predicting mesorectal lymph node metastasis in rectal cancer using preoperative magnetic resonance imaging (MRI) parameters. Methods: We retrospectively analyzed 67 patients with rectal cancer who underwent resection and preoperative pelvic MRI at our institution between April 2015 and December 2023. The MRI-based long- and short-axis diameters of mesorectal lymph nodes were compared with pathological findings to assess their correlation with lymph node metastasis. Receiver operating characteristic (ROC) curve analysis was used to determine the optimal cutoff values for metastasis prediction. Results: The median age was 70.5 years, and 48 were male. Among the 67 patients, 30 had mesorectal lymph node metastasis. At our institution, lymph nodes with a long-axis diameter of ≥ 8 mm on MRI were considered positive for metastasis. Using this threshold, the sensitivity and specificity for predicting mesorectal lymph node metastasis were 0.63 and 0.54, respectively. ROC curve analysis identified cutoff values of 6.9 mm for the long-axis diameter, 4.8 mm for the short-axis diameter, and 0.83 for the short-to-long axis ratio. The areas under the ROC curve for the long-axis, short-axis, and short-to-long axis ratio were 0.81, 0.86, and 0.60, respectively. Conclusions: A preoperative long-axis diameter of ≥ 7 mm and a short-axis diameter of ≥ 5 mm were found to be reliable predictors of mesorectal lymph node metastasis in rectal cancer. Using a 5-mm short-axis cutoff improved diagnostic specificity. These findings require further validation in clinical settings to optimize treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.